Comparison of Multiplexed Platforms for Serum Cytokine Detection in COVID-19 Patients

Explore a comprehensive comparison of multiplexed platforms for detecting serum cytokines in COVID-19 patients in this 44-minute webinar presented by Dr. Holden Maecker and Alex Forrest-Hay. Delve into the evaluation of Luminex, Olink, and the novel Alamar NULISAseq platform, which utilizes a modified proximity ligation assay for highly multiplexed analysis of soluble proteins. Examine the results from a study involving 25 COVID-19 patients and 8 healthy controls, gaining insights into the effectiveness of these platforms in identifying cytokines and related inflammatory markers. Enhance your understanding of cutting-edge techniques for analyzing immune responses in COVID-19 research and their potential implications for diagnostics and treatment strategies.

Comparison of multiplexed platforms for serum cytokine detection in COVID 19 patients